Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tear film stabilization and lubrication refer to the maintenance of a healthy, stable tear film on the ocular surface. The tear film is essential for optical clarity, comfort, and protection of the eye. It consists of three main layers: lipid (outermost), aqueous (middle), and mucin (innermost). Each layer plays a distinct role in stabilizing the tear film and ensuring proper lubrication. Disruption in any component can lead to instability—manifesting as dry eye disease—with symptoms including irritation, blurred vision, discomfort or damage to ocular surfaces. Treatments aim at restoring/stabilizing all layers. While not a single molecular target, the overall process is a therapeutic target for dry eye disease.
Restoring and/or stabilizing tear film layers through lubrication, hydration, and/or anti-inflammatory action.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear Film Stabilization/Lubrication (Ocular Surface).